Effects of lipids in patients with familial hypercholesterolaemia on the kinetics of the sodium-lithium countertransporter

Journal of Human Hypertension

Volumn 14, Issue 9, 2000, Pages 561-565

  Wierzbicki, A S ^a   Hardman, T C ^b   Cheung, J ^a   Lambert Hammill, M ^a   Patel, S ^b   Morrish, Z ^b   Lumb, P J ^a   Lant, A F ^b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Familial hypercholesterolaemia; Sodium lithium countertransport

Indexed keywords

ANTILIPEMIC AGENT; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN B; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LIPOPROTEIN; LITHIUM ION; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; SIMVASTATIN; SODIUM ION; TRIACYLGLYCEROL;

ADULT; ANION EXCHANGE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; FOLLOW UP; HUMAN; INSULIN RESISTANCE; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; REGRESSION ANALYSIS; TRANSPORT KINETICS;

EID: 0033817637     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001097     Document Type: Article

References (27)

1. Controversies surrounding sodium-lithium countertransport
2. Kinetics of sodium-lithium countertransport activity in patients with uncomplicated type I diabetes
3. Increased sodium-lithium countertransport in red cells of patients with essential hypertension
4. Hypertension and sodium-lithium countertransport in Utah pedigrees: Evidence for a major locus inheritance
5. Sodium-lithium countertransport and blood pressure change over time: The Gubbio study
6. Human lymphocyte sodium-hydrogen exchange, the influence of lipids, membrane fluidity and insulin
7. Relation of sodium-lithium counter-transport activity to markers of cardiovascular risk in normotensive subjects
8. Kinetic characteristics of the sodium-lithium countertransporter in subjects with coronary artery disease
9. Plasma lipids affect maximum velocity not sodium affinity of human sodium-lithium countertransport: Distinction from essential hypertension
10. The effect of membrane cholesterol content on ion transport processes in plasma membranes
11. Risk of fatal coronary heart disease in familial hypercholesterolaemia
12. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
13. Ethnic origin and hypertension-associated alterations in sodium-lithium countertransport (SLC) kinetics
14. Kinetic characteristics of the erythrocyte sodium-lithium countertransporter in black normotensive subjects compared with three other ethnic groups
15. + countertransport in essential hypertension: Correlation with membrane lipid levels
16. Sulphhydryl group control of sodium-lithium countertransport kinetics: A membrane protein control abnormality in essential hypertension
17. Influence of plasma phytanic acid levels in Refsum's disease on the behaviour of the erythrocyte membrane sodium-lithium countertransporter
18. Refsum disease diagnostic marker phytanic acid alters the physical state of membrane proteins of liver mitochondria
19. Insulin sensitivity, sodium-lithium countertransport and platelet free calcium concentrations in normotensive men with a family history of hypertension
20. Sodium-lithium countertransport, sodium-hydrogen exchange and membrane microviscosity in patients with hyperlipidaemia
21. Effects of lovastatin treatment on red blood cell and platelet cation transport
22. Lipid-lowering therapy leads to a reduction in sodium-lithium countertransport activity
23. Sodium lithium countertransport is acutely influenced by heparin-induced extracorporeal LDL precipitation
24. Reversible alteration of red cell lithium-sodium countertransport in patients with thyroid disease
25. Lipoprotein lipase correlates positively and hepatic lipase inversely with calcific atherosclerosis in homozygous familial hypercholesterolemia
26. A frequent mutation in lipoprotein lipase (D9N) deteriorates the biochemical and clinical phenotype of familial hypercholesterolemia
27. A common mutation in lipoprotein lipase (N281S) alters lipoprotein phenotype and risk for cardiovascular disease in patients with familial hypercholesterolaemia